As part of ongoing efforts to streamline healthcare logistics in India and make doing business easier, the country’s Ministry of Health and Family Welfare has approved the import of pharmaceutical products through Navi Mumbai Airport. To put the ruling into effect, the Drugs Rules, 1945 had Rule 43A amended.
The number of permitted entry points for pharmaceutical consignments has increased to 42 with the addition of Navi Mumbai Airport, as per the most recent notification. In accordance with the Drugs and Cosmetics Act, 1940, the change was publicised following discussions with the Drugs Technical Advisory Board.
Health Ministry officials claim that the move will enhance logistics, fortify pharmaceutical supply chains, and provide importers more options by opening up a second entry point for pharmaceuticals into India. Pharmaceutical shipments should now be able to flow more quickly and efficiently thanks to the change.
Additionally, the government has been making efforts to streamline regulatory processes for the import of limited quantities of pharmaceuticals intended for research, evaluation, and testing. For imports that were previously subject to Form 11 approval, the Ministry had already suggested changes that would have instituted an acknowledgment-based approach.
While retaining strict regulatory supervision for imported medications, these changes are anticipated to ease compliance requirements, encourage research and innovation, back pharmaceutical startups, and enhance India’s economic climate.
Image: ITLN
Disclaimer: All news articles are sourced through valid sources, and Business Unlimited (BU) doesn’t have any exclusive rights on these pieces. If BU features any exclusive story or article, it will be marked as Exclusive Story.
